GA eSeminar: Regulation of Natural Products - a global challenge



The regulation of natural products is a global challenge, given the multitude of regulatory pathways and different approaches globally. Therefore, GA, the Society for Medicinal Plants and Natural Product research, steps in a series of lectures on Regulatory Affairs for (traditional) herbal medicinal products, herbal food supplements (so called botanicals), and substance-based medical devices, with leading experts from industry, authorities and academia worldwide as lecturers. The aim is to help in differentiating the different market niches for herbal products in the countries of this world and to reveal pros and cons of the categories. Part A of the eSeminar, in autumn 2021, gave an overview of the regulation of mainly supply and quality of the products from different regulatory pathways.
The second issue will be dedicated to the United States and Canada, with lectures on the three key regulatory categories for natural products in the EU:

US Botanical Drug regulation -  Dr. Charles Wu, FDA, Washington DC, US
US Dietary Supplement regulation - Greg Noonan, FDA, Washington DC, US
Canadian Natural Products regulation - Sharda Baichan, Bayer Inc., Mississauga, ON, Canada

The following issues of part B are focussing on East Asia, South and Middle America.
Fr. 25.03.2022, 15:00 Uhr - 17:30 Uhr


Part B:   HMPs and Botanicals: Regulation worldwide
Day 2:   United States and Canada - Botanical Drugs vs. Dietary SupplementsMarch 25, 2022
15:00-17:30 CET
Day 3:   East Asia - Herbal Medicinal Products with a tradition (TCM, AYUSH, etc.) and without (modern herbal medicine)                                              Different time!April 29, 2022
13:00-15:30 CEST
Day 4:   South / Middle America - Herbal Medicinal Products with a tradition and withoutMay 20, 2022
15:00-17:30 CEST